A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donep ...
A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donep ...